Triple

T13038851
Position Surface form Disambiguated ID Type / Status
Subject Sonneratiaceae E326634 entity
Predicate recognizedBy P653 FINISHED
Object APG II system E1016989 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: APG II system | Statement: [Sonneratiaceae, recognizedBy, APG II system]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: APG II system
Context triple: [Sonneratiaceae, recognizedBy, APG II system]
  • A. APG II system chosen
    The APG II system is an influential 2003 update of the Angiosperm Phylogeny Group’s classification that reorganized flowering plant families and orders based on molecular phylogenetic evidence.
  • B. APG IV system
    The APG IV system is the fourth modern classification framework for flowering plants developed by the Angiosperm Phylogeny Group, widely used to organize angiosperm families based on molecular phylogenetic evidence.
  • C. Cordis
    Cordis is a medical device company best known for developing and manufacturing cardiovascular and endovascular products such as stents and catheters.
  • D. APG III classification
    APG III classification is a widely used modern system for classifying flowering plants based on molecular phylogenetic evidence, developed by the Angiosperm Phylogeny Group.
  • E. Acclarent
    Acclarent is a medical device company specializing in minimally invasive ear, nose, and throat (ENT) technologies and solutions.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8076cc45c81908123123f43e69266 completed April 9, 2026, 8:09 p.m.
NER Named-entity recognition batch_69d9804d8e3081909584c93df099859a completed April 10, 2026, 10:57 p.m.
NED1 Entity disambiguation (via context triple) batch_69f70a20a5ec8190bc054b3d7cae003b completed May 3, 2026, 8:41 a.m.
Created at: April 9, 2026, 8:55 p.m.